199 related articles for article (PubMed ID: 19609310)
1. A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies.
Schartl M; Wilde B; Laisney JA; Taniguchi Y; Takeda S; Meierjohann S
J Invest Dermatol; 2010 Jan; 130(1):249-58. PubMed ID: 19609310
[TBL] [Abstract][Full Text] [Related]
2. Genetic, biochemical and evolutionary facets of Xmrk-induced melanoma formation in the fish Xiphophorus.
Meierjohann S; Schartl M; Volff JN
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jul; 138(3):281-9. PubMed ID: 15533786
[TBL] [Abstract][Full Text] [Related]
3. MITF-M plays an essential role in transcriptional activation and signal transduction in Xiphophorus melanoma.
Delfgaauw J; Duschl J; Wellbrock C; Froschauer C; Schartl M; Altschmied J
Gene; 2003 Nov; 320():117-26. PubMed ID: 14597395
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional background effects on a tumor driver gene in different pigment cell types of medaka.
Abdulsahib S; Boswell W; Boswell M; Savage M; Schartl M; Lu Y
J Exp Zool B Mol Dev Evol; 2024 May; 342(3):252-259. PubMed ID: 37877158
[TBL] [Abstract][Full Text] [Related]
5. Expression regulation triggers oncogenicity of xmrk alleles in the Xiphophorus melanoma system.
Regneri J; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jan; 155(1):71-80. PubMed ID: 21527356
[TBL] [Abstract][Full Text] [Related]
6. Melanoma development and pigment cell transformation in xiphophorus.
Wellbrock C; Gómez A; Schartl M
Microsc Res Tech; 2002 Sep; 58(6):456-63. PubMed ID: 12242702
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
8. Xmrk in medaka: a new genetic melanoma model.
Patton EE; Nairn RS
J Invest Dermatol; 2010 Jan; 130(1):14-7. PubMed ID: 20010863
[TBL] [Abstract][Full Text] [Related]
9. Expression signatures of early-stage and advanced medaka melanomas.
Klotz B; Kneitz S; Regensburger M; Hahn L; Dannemann M; Kelso J; Nickel B; Lu Y; Boswell W; Postlethwait J; Warren W; Kunz M; Walter RB; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jun; 208():20-28. PubMed ID: 29162497
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction by the oncogenic receptor tyrosine kinase Xmrk in melanoma formation of Xiphophorus.
Wellbrock C; Gómez A; Schartl M
Pigment Cell Res; 1997; 10(1-2):34-40. PubMed ID: 9170160
[TBL] [Abstract][Full Text] [Related]
11. Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma.
Wellbrock C; Geissinger E; Gómez A; Fischer P; Friedrich K; Schartl M
Oncogene; 1998 Jun; 16(23):3047-56. PubMed ID: 9662338
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional control analyses of the Xiphophorus melanoma oncogene.
Regneri J; Volff JN; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2015 Dec; 178():116-127. PubMed ID: 26348392
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary origin and molecular biology of the melanoma-inducing oncogene of Xiphophorus.
Schartl A; Dimitrijevic N; Schartl M
Pigment Cell Res; 1994 Dec; 7(6):428-32. PubMed ID: 7761351
[TBL] [Abstract][Full Text] [Related]
14. Differences in transcription and promoters of Xmrk-1 and Xmrk-2 genes suggest a role for Xmrk-2 in pigment pattern development in the platyfish, Xiphophorus maculatus.
Woolcock BW; Schmidt BM; Kallman KD; Vielkind JR
Cell Growth Differ; 1994 Jun; 5(6):575-83. PubMed ID: 7522032
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic epidermal growth factor receptor variant Xiphophorus melanoma receptor kinase induces motility in melanocytes by modulation of focal adhesions.
Meierjohann S; Wende E; Kraiss A; Wellbrock C; Schartl M
Cancer Res; 2006 Mar; 66(6):3145-52. PubMed ID: 16540665
[TBL] [Abstract][Full Text] [Related]
16. Melanoma loss-of-function mutants in Xiphophorus caused by Xmrk-oncogene deletion and gene disruption by a transposable element.
Schartl M; Hornung U; Gutbrod H; Volff JN; Wittbrodt J
Genetics; 1999 Nov; 153(3):1385-94. PubMed ID: 10545466
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations in the extracellular domain of the melanoma inducing receptor Xmrk are tumorigenic in vivo.
Winnemoeller D; Wellbrock C; Schartl M
Int J Cancer; 2005 Dec; 117(5):723-9. PubMed ID: 15957173
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Xmrk proto-oncogene of Xiphophorus by overexpression and mutational alterations.
Dimitrijevic N; Winkler C; Wellbrock C; Gómez A; Duschl J; Altschmied J; Schartl M
Oncogene; 1998 Apr; 16(13):1681-90. PubMed ID: 9582016
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Xiphophorus and human melanoma transcriptomes reveals conserved pathway interactions.
Lu Y; Boswell M; Boswell W; Kneitz S; Hausmann M; Klotz B; Regneri J; Savage M; Amores A; Postlethwait J; Warren W; Schartl M; Walter R
Pigment Cell Melanoma Res; 2018 Jul; 31(4):496-508. PubMed ID: 29316274
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppression in Xiphophorus by an accidentally acquired promoter.
Adam D; Dimitrijevic N; Schartl M
Science; 1993 Feb; 259(5096):816-9. PubMed ID: 8430335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
